Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2005
10/20/2005US20050234053 9-oxo-3,4,6,9-tetrahydro-2H-[1,4]-(oxazino, thiazino, or pyrazino)[3,2-b][1,8]naphthyridine-8-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors
10/20/2005US20050234045 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005CA2563502A1 Novel water-soluble prodrug
10/20/2005CA2562399A1 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/19/2005EP1586572A1 Fused pyrazolyls as anti-cancer drugs
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005CN1685232A Novel fluorescent label compounds
10/19/2005CN1683521A Agricultural antibiotic strain for producing fungus killer and its preparing process
10/19/2005CN1683372A Method for extracting protopine from decumbent corydalis tuber
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956035 Isoquinoline derivatives and methods of use thereof
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/13/2005WO2005095409A2 Tetrahydroquinoline derivatives and a process for preparing the same
10/13/2005WO2005095401A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005WO2005095387A1 Tricyclic pyrazole kinase inhibitors
10/13/2005WO2005095362A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
10/13/2005WO2005094878A1 Composition having antitumor effect
10/13/2005WO2005094833A1 Novel n-substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
10/13/2005WO2005094828A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005US20050228186 Simple stereocontrolled synthesis of salinosporamide A
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050228179 Thionation of a carbonyl compound comprising a nitrile group, the presence of a decoy agent comprising a nitrile group
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228013 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/13/2005US20050228010 Antidepressant azahetorocyclylmethyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
10/13/2005US20050228009 2-(4-benzo[b]thiophen-3-yl-3,6-dihydro-2H-pyridin-1-ylmethyl)-2,3-dihydro-7H -[1,4]dioxino[2,3-e]indole; serotonin reuptake and serotonin receptor inhibitor; antidepressant, anxiolytic agent; dysthymia, panic disorder, attention deficit disorder obsessive, obesity, drug abuse, sexual dysfunction
10/13/2005US20050228006 Process and intermediates for obtaining 1-(1H-benzimidazol-2-YL)-4-(2-aminopyrimidine)piperidine derivatives
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227992 Protein kinase inhibitors
10/13/2005US20050227971 Thioamide derivatives as progesterone receptor modulators
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005CA2560691A1 Tricyclic pyrazole kinase inhibitors
10/13/2005CA2558019A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005CA2557719A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/12/2005EP1583537A2 Piperidine compounds as antibacterials
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP0954522B1 Novel substituted naphthopyrans
10/12/2005EP0912547B1 New substituted pyridyl keto enols
10/12/2005CN1681830A Novel chemical substance having morphogenetic and growth-accelerating activities
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681822A Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/12/2005CN1681821A Antidepressivt virkende cykloalkylaminderivater AV heterocykle-kondenserte benzodioksaner
10/12/2005CN1681820A Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
10/12/2005CN1681819A 6, 7-dihydro-5H-pyrazolo[1, 2-a]pyrazol-1-ones which control inflammatory cytokines
10/12/2005CN1681804A Sulphonamide derivatives and their use as TACE inhibitors
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1680383A Indicated tetraodotoxin, preparation and use thereof
10/12/2005CN1680382A Preparation of tetraodotoxin by two-step resin method and tetraodotoxin preparation thereof
10/12/2005CN1680381A Preparation of S-tricyctic lactone
10/12/2005CN1680372A New benzo[b]chromeno-naphthyridin-7-one and pyrano[2', 3':7, 8] quino[2, 3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680334A Fused pyrazolyls
10/12/2005CN1680287A Ketol fatty acid derivatives and plant growth regulators
10/12/2005CN1680272A C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953787 5HT2C receptor modulators
10/11/2005US6953679 Biosynthesis with enzyme or microorganism, catalyzing hydroxylation reaction, useful as modulators of nuclear hormone receptor, anticarcinogenic agents, immunomodulators, steroid mimic
10/06/2005WO2005092995A1 Reversible piezochromic systems
10/06/2005WO2005092897A2 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005WO2005092896A1 Compound for inhibiting tyrosine kinase activity of ddr2 protein
10/06/2005WO2005092895A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005WO2005092858A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
10/06/2005WO2005075978A3 Time-temperature indicator based on valence isomerizations
10/06/2005WO2005072066A3 Preventive or therapeutic agent for diabetic maculopathy
10/06/2005WO2005066135A3 Pyrrole and pyrazole daao inhibitors
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222425 Process for making amide acetals
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005US20050222138 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
10/06/2005US20050221498 Quantitative method of determining beryllium or a compound thereof in a sample
10/06/2005DE102004014620A1 2,4,6-phenylsubstituierte cyclische Ketoenole 2,4,6-substituted cyclic ketoenols
10/06/2005CA2563164A1 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005CA2561488A1 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists
10/06/2005CA2561076A1 2,4,6-phenylsubstituted cyclic ketoenoles
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1581526A1 Benzisoxazole derivatives useful as inhibitors of protein kinases
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1221554C Pyrano [2, 3-C] imidazo[-1, 2-A] pyridine derivatives and mecicine composition for treatment of traitement gastrointestinal disorders
10/05/2005CN1221553C Tricyclic imidazopyridines and medicine composition thereof
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951952 which exhibit a first color when in crystalline form and a second different color when in the liquid, amorphous form; for thermal imaging
10/04/2005US6951942 Glucocorticoid-selective anti-inflammatory agents
10/04/2005US6951868 Central nervous system disorders, gastrointestinal disorders;side effect reduction
10/04/2005US6951866 Bicyclic pyrimidine compounds and therapeutic use thereof
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 298